Table 3 Predictive efficacy of inflammatory factors and tumor glucose metabolism for pCR.

From: Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism

 

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

Accuracy (%)

Pre-OP NLR < 5.4

84.2

80.2

77.4

87.7

82.7

ΔNLR < 3

89.5

80.0

78.5

90.3

84.3

ΔSUV > 7.2

75.9

56.4

56.0

70.4

60.5

ΔSUV ratio > 58%

77.8

49.2

56.0

72.7

62.2

  1. PPV positive predict value, NPV negative predict value, pre-OP NLR neutrophil–lymphocyte ratio before operation, CCRT concurrent chemoradiotherapy, OP operation, pre-CCRT NLR neutrophil–lymphocyte ratio before concurrent chemoradiotherapy, pre-OP NLR neutrophil–lymphocyte ratio before operation, ΔNLR the change of neutrophil–lymphocyte ratio before and after concurrent chemoradiotherapy, ΔSUV the change of maximum standardized uptake value of the esophageal tumor before and after concurrent chemoradiotherapy.
Back to article page